{"version":"1.0","type":"link","title":"Metabolic Response to CDK4/6 Inhibition in ER+ Breast Cancer Creates a Therapeutic Vulnerability in Drug-Tolerant Persister Cells.","author_name":"Yang H 외","author_url":"https://prs-insight.online/author/Yang%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/76586","thumbnail_width":1200,"thumbnail_height":630}